UNCLAIMED
Iterative Health
Overview
Iterative Health is a software company based in the United States, founded in 2017, with a focus on advancing gastrointestinal (GI) clinical research through the application of machine learning (ML) technologies. The company is engaged in developing innovative solutions aimed at improving endoscopic assessments, particularly for conditions such as inflammatory bowel disease (IBD). Recent research presented at the ACG 2024 conference highlights Iterative Health's commitment to addressing challenges in GI endoscopy by leveraging ML models to enhance the accuracy and efficiency of disease assessments. Their work emphasizes generating real-world evidence to inform treatment selection and improve clinical care outcomes. The company collaborates with leading researchers and institutions to refine endoscopic assessment methodologies, ultimately aiming to facilitate better drug development processes and enhance long-term patient outcomes. With a workforce of between 51 and 200 employees, Iterative Health operates within the software industry, generating significant revenue while contributing to advancements in healthcare technology.